This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


3bva

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:3bva.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:3bva.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_3bva| PDB=3bva | SCENE= }}
{{STRUCTURE_3bva| PDB=3bva | SCENE= }}
-
'''Cystal structure of HIV-1 Active Site Mutant D25N and p2-NC analog inhibitor'''
+
===Cystal structure of HIV-1 Active Site Mutant D25N and p2-NC analog inhibitor===
-
==Overview==
+
<!--
-
All aspartic proteases including retroviral proteases share the triplet DTG critical for the active site geometry and catalytic function. These residues interact closely in the active, dimeric structure of HIV-1 protease (PR). We have systematically assessed the effect of the D25N mutation on the structure and stability of the mature HIV-1 protease (PR) monomer and dimer. The D25N mutation (PR(D25N)) increases the equilibrium dimer dissociation constant by a factor &gt;100-fold (1.3 +/- 0.09 muM) relative to PR. In the absence of inhibitor, NMR studies reveal clear structural differences between PR and PR(D25N) in the relatively mobile P1 loop (residues 79-83) and flap regions, and differential scanning calorimetric (DSC) analyses show that the mutation lowers the stabilities of both the monomer and dimer folds by 5 and 7.3 degrees C, respectively. Only minimal differences are observed in high resolution crystal structures of PR(D25N) complexed to darunavir (DRV), a potent clinical inhibitor, or a non-hydrolysable substrate analogue (RPB), as compared to PR-DRV and PR-RPB complexes. Although complexation with RPB stabilizes both dimers, the effect on their Tm is smaller for PR(D25N) (6.2 degrees C) than for PR (8.7 degrees C). The Tm of PR(D25N)/DRV increases by only 3 degrees C relative to free PR(D25N), as compared to a 22 degrees C increase for PR/DRV, and the mutation increases the ligand dissociation constant of PR(D25N)/DRV by a factor of ~10(6) relative to PR/DRV. These results suggest that interactions mediated by the catalytic Asp residues make a major contribution to the tight binding of DRV to PR.
+
The line below this paragraph, {{ABSTRACT_PUBMED_18281688}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 18281688 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_18281688}}
==About this Structure==
==About this Structure==
Line 20: Line 24:
==Reference==
==Reference==
Effect of the active-site D25N mutation on the structure, stability and ligand binding of the mature HIV-1 protease., Sayer JM, Liu F, Ishima R, Weber IT, Louis JM, J Biol Chem. 2008 Feb 15;. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/18281688 18281688]
Effect of the active-site D25N mutation on the structure, stability and ligand binding of the mature HIV-1 protease., Sayer JM, Liu F, Ishima R, Weber IT, Louis JM, J Biol Chem. 2008 Feb 15;. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/18281688 18281688]
 +
 +
Solution structure of the mature HIV-1 protease monomer: insight into the tertiary fold and stability of a precursor., Ishima R, Torchia DA, Lynch SM, Gronenborn AM, Louis JM, J Biol Chem. 2003 Oct 31;278(44):43311-9. Epub 2003 Aug 21. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/12933791 12933791]
 +
 +
Kinetic, stability, and structural changes in high-resolution crystal structures of HIV-1 protease with drug-resistant mutations L24I, I50V, and G73S., Liu F, Boross PI, Wang YF, Tozser J, Louis JM, Harrison RW, Weber IT, J Mol Biol. 2005 Dec 9;354(4):789-800. Epub 2005 Oct 21. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/16277992 16277992]
[[Category: HIV-1 retropepsin]]
[[Category: HIV-1 retropepsin]]
[[Category: Human immunodeficiency virus 1]]
[[Category: Human immunodeficiency virus 1]]
Line 31: Line 39:
[[Category: Hydrolase]]
[[Category: Hydrolase]]
[[Category: Mutation]]
[[Category: Mutation]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 21:08:48 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 08:51:17 2008''

Revision as of 05:51, 29 July 2008

Image:3bva.png

Template:STRUCTURE 3bva

Cystal structure of HIV-1 Active Site Mutant D25N and p2-NC analog inhibitor

Template:ABSTRACT PUBMED 18281688

About this Structure

3BVA is a Single protein structure of sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.

Reference

Effect of the active-site D25N mutation on the structure, stability and ligand binding of the mature HIV-1 protease., Sayer JM, Liu F, Ishima R, Weber IT, Louis JM, J Biol Chem. 2008 Feb 15;. PMID:18281688

Solution structure of the mature HIV-1 protease monomer: insight into the tertiary fold and stability of a precursor., Ishima R, Torchia DA, Lynch SM, Gronenborn AM, Louis JM, J Biol Chem. 2003 Oct 31;278(44):43311-9. Epub 2003 Aug 21. PMID:12933791

Kinetic, stability, and structural changes in high-resolution crystal structures of HIV-1 protease with drug-resistant mutations L24I, I50V, and G73S., Liu F, Boross PI, Wang YF, Tozser J, Louis JM, Harrison RW, Weber IT, J Mol Biol. 2005 Dec 9;354(4):789-800. Epub 2005 Oct 21. PMID:16277992

Page seeded by OCA on Tue Jul 29 08:51:17 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/3bva"
Personal tools